Difference between revisions of "Profile drafts"
Jump to navigation
Jump to search
m |
|||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| + | |||
| + | Short Title: QIBA DRAFT Profile: SPECT dopamine transporters | ||
| + | |||
| + | *[[Media:001.QIBA_SPECT_Profile.v0.1_2016.03.21.some spring cleaning.docx | QIBA DRAFT Profile with tracked changes for recent additions - {Dr. Mozley}]] ''March 21, 2016'' | ||
| + | |||
| + | *[[Media:001.QIBA_SPECT_Profile.v0.1_2016.03.16.some tracked changes-yuni.docx | QIBA DRAFT Profile with tracked changes for recent additions - {Dr. Dewaraja}]] ''March 16, 2016'' | ||
| + | |||
| + | *[[Media:001.QIBA_SPECT_Profile.v0.1_2016.03.16.some tracked changes.docx | QIBA DRAFT Profile with tracked changes for recent additions - {Dr. Mozley}]] ''March 16, 2016'' | ||
| + | |||
| + | *[[Media:001.QIBA_SPECT_Profile.v0.1_2016.03.16.docx | QIBA DRAFT Profile - {Dr. Miyaoka}]] ''March 15, 2016'' | ||
| + | |||
| + | *[[Media:Draft Profile Section on Image Analysis 3.10.docx | QIBA DRAFT Profile Section 3.10 on Image Analysis - {Drs. Miyaoka and Seibyl}]] ''March 8, 2016'' | ||
| + | |||
| + | *[[Media:001.QIBA_SPECT_Profile.v0.1_2016.02.17.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {comments from Mr. Cella}]] ''February 17, 2016'' | ||
*[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2_NOedits.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski}]] ''February 16, 2016'' | *[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2_NOedits.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski}]] ''February 16, 2016'' | ||
| − | *[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease | + | *[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {comments - Dr. Zimmerman}]] ''February 16, 2016'' |
| − | *[[Media:001 QIBA_SPECT_Profile v0 1 JCD 2016 01 21.docx| QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease | + | *[[Media:001 QIBA_SPECT_Profile v0 1 JCD 2016 01 21.docx| QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {Dr. Seibyl}]] ''January 22, 2016'' |
Latest revision as of 20:27, 17 March 2017
Short Title: QIBA DRAFT Profile: SPECT dopamine transporters
- QIBA DRAFT Profile - {Dr. Miyaoka} March 15, 2016
- QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {comments from Mr. Cella} February 17, 2016
- QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski} February 16, 2016